Lupin Pharmaceuticals Inc | eHealth Magazine

Say something

Lupin gets FDA nod for anti-allergic tablets

Drug firm Lupin announced it has been granted final approval by the United states Food and Drug Administration (USFDA) for antihistamine Desloratadine tablets, used for treating allergies.

By Elets News Network

Government of India powers a population-scale vaccine drive on AWS

Amazon closes a $3.9 billion deal to acquire a primary-care clinic operator

Downturn impact: Healthtech startup MFine hands pink slip to over 500 employees

Transasia unveils a range of IVD solutions with enhanced user experience

AIIMS Jodhpur collaborates with Microsoft India to establish a Mixed Reality Center of Excellence

Tags: allergies, Bombay Stock Exchange, clarinex, ims health, lupin, Lupin Pharmaceuticals Inc, pharmaceutical, Schering-Plough, United States, United States Food and Drug Administration, USD

Categories

Lupin gets FDA nod for anti-allergic tablets

Corporate Updates

Government of India powers a population-scale vaccine drive on AWS

Amazon closes a $3.9 billion deal to acquire a primary-care clinic operator

Downturn impact: Healthtech startup MFine hands pink slip to over 500 employees

Transasia unveils a range of IVD solutions with enhanced user experience

AIIMS Jodhpur collaborates with Microsoft India to establish a Mixed Reality Center of Excellence

Flipkart Health+ App Launched

Subscribe To Our Newsletter

Medical Education

Digitisation is significantly boosting medical education and healthcare: Mansukh Mandaviya

Yogi proposes Rs 2,100 crore for medical colleges in 14 districts in UP budget

Yogi Government to introduce 5 new health-related courses to UP Skill Development Mission

UP government to complete construction of Atal Bihari Vajpayee Medical University in 2022

PM Modi: India to obtain a record number of new doctors in the next 10 years

Digital CME: Changing the Face of Learning

NEET UG is to be held in 14 cities abroad for the first time

Revolutionizing Healthcare Delivery: Striking the Virtual-Physical Balance

Healthcare innovations transforming patient experience: Purshottam Solanki, Dr. L H Hiranandani Hospital

Sustainable and Innovative Healthcare Infrastructure: HOSMAC's Journey and Vision

Tags: allergies, Bombay Stock Exchange, clarinex, ims health, lupin, Lupin Pharmaceuticals Inc, pharmaceutical, Schering-Plough, United States, United States Food and Drug Administration, USD

document.write(currentDate);

Categories

Corporate Updates

Subscribe To Our Newsletter

Medical Education